These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33015157)

  • 61. Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 (ISAR-DESIRE 3 and ISAR-DESIRE 4) trials.
    Colleran R; Joner M; Kufner S; Altevogt F; Neumann FJ; Abdel-Wahab M; Bohner J; Valina C; Richardt G; Zrenner B; Cassese S; Ibrahim T; Laugwitz KL; Schunkert H; Kastrati A; Byrne RA;
    Int J Cardiol; 2018 Feb; 252():57-62. PubMed ID: 29203209
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
    Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro.
    Kastl SP; Katsaros KM; Krychtiuk KA; Jägersberger G; Kaun C; Huber K; Wojta J; Speidl WS
    PLoS One; 2020; 15(5):e0232483. PubMed ID: 32392256
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
    Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Let-7f: A New Potential Circulating Biomarker Identified by miRNA Profiling of Cells Isolated from Human Abdominal Aortic Aneurysm.
    Spear R; Boytard L; Blervaque R; Chwastyniak M; Hot D; Vanhoutte J; Lamblin N; Amouyel P; Pinet F
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694153
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
    Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
    Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents.
    Sun J; Yu H; Liu H; Pu D; Gao J; Jin X; Liu X; Yan A
    J Clin Lab Anal; 2020 Mar; 34(3):e23108. PubMed ID: 31729103
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
    Nishino M; Lee Y; Nakamura D; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Invasive Cardiol; 2012 Oct; 24(10):478-83. PubMed ID: 23043029
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty.
    Adamian M; Colombo A; Briguori C; Nishida T; Marsico F; Di Mario C; Albiero R; Moussa I; Moses JW
    J Am Coll Cardiol; 2001 Sep; 38(3):672-9. PubMed ID: 11527615
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
    Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association between plasma BMP-2 and in-stent restenosis in patients with coronary artery disease.
    Zheng WP; Yang M; Su LX; Ning Y; Wen WW; Xin MK; Zhao X; Zhang M
    Clin Chim Acta; 2017 Aug; 471():150-153. PubMed ID: 28558956
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
    L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
    Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
    Ganesh SK; Skelding KA; Mehta L; O'Neill K; Joo J; Zheng G; Goldstein J; Simari R; Billings E; Geller NL; Holmes D; O'Neill WW; Nabel EG
    Pharmacogenomics; 2004 Oct; 5(7):952-1004. PubMed ID: 15469413
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction.
    Li H; Zhang P; Li F; Yuan G; Wang X; Zhang A; Li F
    Biomed Res Int; 2019; 2019():5012648. PubMed ID: 31179325
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulating microRNAs in suspected stable coronary artery disease: A coronary computed tomography angiography study.
    de Gonzalo-Calvo D; Vilades D; Martínez-Camblor P; Vea À; Nasarre L; Sanchez Vega J; Leta R; Carreras F; Llorente-Cortés V
    J Intern Med; 2019 Sep; 286(3):341-355. PubMed ID: 31141242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.